The role of 18F-FDG-PET/CT in the preoperative staging and posttherapy follow up of gastriccancer: Comparison with spiral CT

World Journal of Surgical Oncology

Volumn 9, Issue , 2011, Pages

  Ozkan, Elgin ^a   Araz, Mine ^a   Soydal, Cigdem ^a   Kucuk, Ozlem N ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

FDG PET CT; Gastric cancer; Spiral CT

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ABDOMINAL RADIOGRAPHY; ACCURACY; ADULT; ARTICLE; BONE METASTASIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTESTINE WALL; INTESTINE WALL METASTASIS; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STOMACH ADENOCARCINOMA; THORAX RADIOGRAPHY; TREATMENT OUTCOME; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; GASTRECTOMY; METHODOLOGY; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; REPRODUCIBILITY; STOMACH TUMOR;

DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 79960275919     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-9-75     Document Type: Article

References (18)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108. 10.3322/canjclin.55.2.74, 15761078.
2. Chandanos E, Lagergren J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer 2008, 44(16):2397-403. 10.1016/j.ejca.2008.07.031, 18755583.
3. Kelly S, Harris KM, Berry E, Hutton J, Roderick P, Cullingworth J, Gathercole L, Smith MA. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 2001, 49(4):534-539. 10.1136/gut.49.4.534, 1728456, 11559651.
4. Willis S, Truong S, Gribnitz S, Fass J, Schumpelick V. Endoscopic ultrasonography in the preoperative staging of gastric cancer: accuracy and impact on surgical therapy. Surg Endosc 2000, 14(10):951-954. 10.1007/s004640010040, 11080410.
5. Bhandari S, Shim CS, Kim JH, Jung IS, Cho JY, Lee JS, Lee MS, Kim BS. Usefulness of three-dimensional, multidetector row CT (virtual gastroscopy and multiplanar reconstruction) in the evaluation of gastric cancer: a comparison with conventional endoscopy, EUS, and histopathology. Gastrointest Endosc 2004, 59(6):619-626. 10.1016/S0016-5107(04)00169-5, 15114303.
6. Habermann CR, Weiss F, Riecken R, Honarpisheh H, Bohnacker S, Staedtler C, Dieckmann C, Schoder V, Adam G. Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology 2004, 230(2):465-471. 10.1148/radiol.2302020828, 14752188.
7. Kim KW, Choi BI, Han JK, Kim TK, Kim AY, Lee HJ, Kim YH, Choi JI, Do KH, Kim HC, Lee MW. Postoperative anatomic and pathologic findings at CT following gastrectomy. Radiographics 2002, 22(2):323-336.
8. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002, 224(3):748-756. 10.1148/radiol.2243011362, 12202709.
9. Lynch TB. Introduction. PET/CT in Clinical Practice 2007, 1-15. Springer-Verlag London.
10. Dassen AE, Lips DJ, Hoekstra CJ, Pruijt JF, Bosscha K. FDG-PET has no definite role in preoperative imaging in gastric cancer. Eur J Surg Oncol 2009, 35(5):449-55.
11. Lim JS, Yun MJ, Kim MJ, Hyung WJ, Park MS, Choi JY, Kim TS, Lee JD, Noh SH, Kim KW. CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics 2006, 26(1):143-56. 10.1148/rg.261055078, 16418249.
12. Kim SK, Kang W, Lee JS Kim HK, Kim HK, Chang HJ, Choi JY, Lee JH, Ryu KW, Kim YW, Bae JM. Assesment of Lymph node metastasis using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging 2006, 33(2):148-155. 10.1007/s00259-005-1887-8, 16228236.
13. Yun M, Lim JS, Noh SH, Hyung WJ, Cheong JH, Bong JK, Cho A, Lee JD. Lymph Node Staging of Gastric Cancer Using18F-FDG PET: A Comparison Study with CT. J Nucl Med 2005, 46(10):1582-1588.
14. Podoloff DA, Advani RH, Allred C, Benson AB, Brown E, Burstein HJ, Carlson RW, Coleman RE, Czuczman MS, Delbeke D, Edge SB, Ettinger DS, Grannis FW, Hillner BE, Hoffman JM, Kiel K, Komaki R, Larson SM, Mankoff DA, Rosenzweig KE, Skibber JM, Yahalom J, Yu JM, Zelenetz AD. NCCN Task Force Report: Positron Emission Tomography (PET)/Computed Tomography(CT) Scanning in Cancer. J Natl Compr Canc Netw 2007, 5(Suppl 1):S1-S22. quiz S23-2.
15. Yoshioka T, Yamaguchi K, Kubota K, Saginoya T, Yamazaki T, Ido T, Yamaura G, Takahashi H, Fukuda H, Kanamaru R. Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer. J Nucl Med 2003, 44(5):690-9.
16. Suttie SA, Welch AE, Park KG. Positron emission tomography for monitoring response to neoadjuvant therapy in patients with oesophageal and gastro-oesophageal junction carcinoma. Eur J Surg Oncol 2009, 35(10):1019-29.
17. Hur H, Kim SH, Kim W, Song KY, Park CH, Jeon HM. The efficacy of preoperative PET/CT for prediction of curability in surgery for locally advanced gastric carcinoma. World J of Surg Oncol 2010, 8(86).
18. Fogelman I, Cook G, Israel O, Van der Wall H. Positron Emission Tomography and Bone Metastases. Semin Nucl Med 2005, 35:135-142. 10.1053/j.semnuclmed.2004.11.005, 15765376.